Alpha Paradigm Partners, LLC Gilead Sciences, Inc. Transaction History
Alpha Paradigm Partners, LLC
- $239 Million
- Q4 2022
A detailed history of Alpha Paradigm Partners, LLC transactions in Gilead Sciences, Inc. stock. As of the latest transaction made, Alpha Paradigm Partners, LLC holds 1,491 shares of GILD stock, worth $137,186. This represents 0.05% of its overall portfolio holdings.
Number of Shares
1,491
Previous 3,349
55.48%
Holding current value
$137,186
Previous $207,000
38.16%
% of portfolio
0.05%
Previous 0.09%
Shares
7 transactions
Others Institutions Holding GILD
# of Institutions
1,926Shares Held
992MCall Options Held
10.5MPut Options Held
9.75M-
Black Rock Inc. New York, NY121MShares$11.1 Billion0.19% of portfolio
-
Vanguard Group Inc Valley Forge, PA115MShares$10.6 Billion0.18% of portfolio
-
Capital World Investors Los Angeles, CA76.5MShares$7.04 Billion1.03% of portfolio
-
Capital Research Global Investors Los Angeles, CA61.8MShares$5.69 Billion1.12% of portfolio
-
State Street Corp Boston, MA60.2MShares$5.54 Billion0.21% of portfolio
About GILEAD SCIENCES, INC.
- Ticker GILD
- Exchange NASDAQ
- Sector Healthcare
- Industry Drug Manufacturers—General
- Shares Outstandng 1,253,369,984
- Market Cap $115B
- Description
- Gilead Sciences, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines in the areas of unmet medical need in the United States, Europe, and internationally. The company provides Biktarvy, Genvoya, Descovy, Odefsey, Truvada, Complera/ Eviplera, Stribild, and Atripla products for the treatment of HIV/AIDS; Veklury, a...